|
MRPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29130000026123E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.45269999998854E-06 |
| Normal-vs-Stage2 |
1.437650E-03 |
| Normal-vs-Stage3 |
2.49849996247775E-09 |
| Normal-vs-Stage4 |
6.861000E-03 |
| Stage1-vs-Stage2 |
9.889200E-01 |
| Stage1-vs-Stage3 |
2.442700E-03 |
| Stage1-vs-Stage4 |
8.829000E-01 |
| Stage2-vs-Stage3 |
3.295600E-02 |
| Stage2-vs-Stage4 |
9.077000E-01 |
| Stage3-vs-Stage4 |
1.158850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79179999948431E-07 |
| Normal-vs-AfricanAmerican |
1.181030E-04 |
| Normal-vs-Asian |
3.439900E-03 |
| Caucasian-vs-AfricanAmerican |
4.057000E-01 |
| Caucasian-vs-Asian |
5.756400E-01 |
| AfricanAmerican-vs-Asian |
4.362200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33589999956807E-07 |
| Normal-vs-Female |
6.8496000005247E-07 |
| Male-vs-Female |
4.588000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.43079999999729E-05 |
| Normal-vs-Extreme_Weight |
3.68839999997927E-06 |
| Normal-vs-Obese |
2.74489999996241E-06 |
| Normal-vs-Extreme_Obese |
2.326200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.137400E-01 |
| Normal_Weight-vs-Obese |
7.152600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.291000E-01 |
| Extreme_Weight-vs-Obese |
4.002400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.058000E-01 |
| Obese-vs-Extreme_Obese |
4.388000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.140900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.32879999956448E-07 |
| Normal-vs-Age(61-80Yrs) |
1.0435999999725E-06 |
| Normal-vs-Age(81-100Yrs) |
9.69290000000234E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.080800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.819000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.961000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.721600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.482400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.737600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.7235999999764E-06 |
| Normal-VS-Type2 PRCC |
6.13590000031472E-07 |
| Normal-VS-KIRP CIMP |
8.08100031335357E-10 |
| Normal-VS-Unclassified PRCC |
2.87610000038185E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.592980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.83209999998968E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
3.064300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.45019999999263E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.437200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.977400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20389999969106E-07 |
| Normal-vs-N1 |
2.0518999832575E-09 |
| Normal-vs-N2 |
4.32060000000734E-05 |
| N0-vs-N1 |
1.836050E-01 |
| N0-vs-N2 |
9.541700E-02 |
| N1-vs-N2 |
1.917820E-01 |
|
|
